Does a strong family history of breast cancer automatically rule out menopausal hormone therapy?

A strong family history of breast cancer does NOT automatically rule out menopausal hormone therapy (MHT). Here at Alloy, we follow the latest evidence and expert guidelines, which make it clear that family history alone is not a contraindication for MHT. In fact, both The Menopause Society and leading experts like Dr. Avrum Bluming and Dr. Corinne Menn emphasize that your personal risk should be assessed individually, and that MHT can be considered even if you have a family history or are a BRCA carrier (but have not had breast cancer yourself).

Key points to know:

  • Family history of breast cancer does not disqualify you from using MHT.
  • The decision to use hormone therapy should be based on your individual risk, preferences, and a discussion with a menopause-trained healthcare provider.
  • Current evidence shows that bioidentical estrogen and progesterone (the type offered at Alloy) do not increase breast cancer risk.
  • If you have a strong family history, genetic testing and enhanced screening may be recommended, but this is separate from the decision about MHT.

For a deeper dive, check out these helpful resources:

If you’re interested in learning about Alloy’s bioidentical hormone therapy options, visit our product page or start with our online assessment.

At Alloy, we’re here to empower you with science-backed information and personalized care!


This answer was created using the following resources: